MOR — Morphosys AG Income Statement
0.000.00%
Last trade - 00:00- €2.55bn
- €2.31bn
- €238.28m
Annual income statement for Morphosys AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 71.8 | 328 | 180 | 278 | 238 |
| Cost of Revenue | |||||
| Gross Profit | 68.4 | 309 | 147 | 230 | 187 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 179 | 301 | 686 | 503 | 492 |
| Operating Profit | -107 | 26.7 | -506 | -224 | -254 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -107 | 22.5 | -591 | 17.5 | -191 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -103 | 97.9 | -514 | -151 | -190 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -103 | 97.9 | -514 | -151 | -190 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -103 | 97.9 | -514 | -151 | -190 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -3.05 | 3.21 | -10.9 | -4.26 | -5.19 |
| Dividends per Share |